Related Experiment Video

Updated: Aug 11, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomide

Richard Quek, Soon Thye Lim, Simon Ong

    Acta Oncologica (Stockholm, Sweden)
    |February 9, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...